about
Emodin, a natural product, selectively inhibits 11beta-hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet-induced obese miceSteroid Receptor-Associated Immunophilins: A Gateway to Steroid SignallingAdipogenesisEnergy metabolism in the liverFKBP51 reciprocally regulates GRα and PPARγ activation via the Akt-p38 pathwayDiscovery of glucocorticoid receptor-beta in mice with a role in metabolismCorticosteroid receptor expression in a teleost fish that displays alternative male reproductive tactics.Disruption of histone modification and CARM1 recruitment by arsenic represses transcription at glucocorticoid receptor-regulated promoters.The helix 1-3 loop in the glucocorticoid receptor LBD is a regulatory element for FKBP cochaperones.Glucocorticoid receptor β stimulates Akt1 growth pathway by attenuation of PTEN.FKBP51 controls cellular adipogenesis through p38 kinase-mediated phosphorylation of GRα and PPARγ.Susceptibility to diet-induced hepatic steatosis and glucocorticoid resistance in FK506-binding protein 52-deficient mice.FOXO1-dependent up-regulation of MAP kinase phosphatase 3 (MKP-3) mediates glucocorticoid-induced hepatic lipid accumulation in miceAge and tissue specific differences in the development of acute insulin resistance following injuryIncreased glucocorticoid receptor expression and activity mediate the LPS resistance of SPRET/EI mice.Circulating cortisol-associated signature of glucocorticoid-related gene expression in subcutaneous fat of obese subjects.LXRβ is required for glucocorticoid-induced hyperglycemia and hepatosteatosis in mice.Novel nongenomic signaling by glucocorticoid may involve changes to liver membrane order in rainbow trout.Disruption of the acyl-CoA-binding protein gene delays hepatic adaptation to metabolic changes at weaningEffects of antisense-mediated inhibition of 11β-hydroxysteroid dehydrogenase type 1 on hepatic lipid metabolismEffect of inhaled corticosteroids on glycemic status.Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial.microRNA-379 couples glucocorticoid hormones to dysfunctional lipid homeostasis.REDD1 (regulated in development and DNA damage response 1) expression in skeletal muscle as a surrogate biomarker of the efficiency of glucocorticoid receptor blockade.Combined treatment with dexamethasone and raloxifene totally abrogates osteoporosis and joint destruction in experimental postmenopausal arthritis.Histological Remission during Corticosteroid Therapy of Overlapping Nonalcoholic Steatohepatitis and Autoimmune Hepatitis: Case Report and Literature Review.Protein phosphatase 5 mediates lipid metabolism through reciprocal control of glucocorticoid receptor and peroxisome proliferator-activated receptor-γ (PPARγ).Obesity, Asthma, and the Microbiome.The role of CREB-H transcription factor in triglyceride metabolism.Characterization of transcription factor response kinetics in parallel.Activation of the farnesoid X receptor induces hepatic expression and secretion of fibroblast growth factor 21Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer development.Maternal psychological stress-induced developmental disability, neonatal mortality and stillbirth in the offspring of Wistar albino ratsDexamethasone treatment alters insulin, leptin, and adiponectin levels in male mice as observed in DIO but does not lead to alterations of metabolic phenotypes in the offspringWhole-organism screening for gluconeogenesis identifies activators of fasting metabolism.Hydroxypropyl methylcellulose, a viscous soluble fiber, reduces insulin resistance and decreases fatty liver in Zucker Diabetic Fatty rats.Stress responsiveness of the hypothalamic-pituitary-adrenal axis: age-related features of the vasopressinergic regulation.Comparative study on the effects of type 1 and type 2 diabetes on structural changes and hormonal output of the adrenal cortex in male Wistar ratsStress and Its Effects on Glucose Metabolism and 11β-HSD Activities in Rats Fed on a Combination of High-Fat and High-Sucrose Diet with Glycyrrhizic Acid.Programming Effects of Prenatal Glucocorticoid Exposure with a Postnatal High-Fat Diet in Diabetes Mellitus.
P2860
Q24627436-C027C615-64E3-4FDD-BF6B-BA94E010917CQ26801686-B959743B-27D6-4F57-9406-539E23250DD5Q26828614-CD45C3FF-4BE8-47A1-AE53-25F83FFE84E6Q26996783-12A5D0BD-10EB-414E-900C-95884C579EBAQ28391433-A90E6E76-07D9-42BC-BAAC-D58A0E593912Q28592231-3615C417-C13B-4A4F-9DE6-1C6A9CF39895Q30477795-1A532FAC-F013-4C01-8A68-DF9DF8FF3D24Q33496730-899E925E-609E-4D59-875E-EAB95B1ABCE4Q33633104-9EFCAFC4-D0DF-4457-B86C-D471B6BE1595Q33793042-62914497-1395-4B21-A4C8-19B57D75B210Q33977397-62FB46C9-F8B9-4FF9-8E61-64E0ECB9EE35Q33993835-C240F233-0113-4E55-8158-408824DEA731Q34036204-BBEF95BF-9FFF-45C4-BC04-862E0022D23FQ34089832-4B605B10-34EC-4321-8D80-22C411D371C5Q34155493-7B575FE2-016C-42B1-8EC2-A56744B6E33BQ34349236-AFBC662E-B92C-4EBF-8DF4-CD5DFA315A49Q34428893-191F3EA4-7163-423B-B9AE-BAB3C8E5D09AQ34442326-319ADF27-A549-4FA5-9AA7-2B7A7B923A01Q34536893-E39C9341-1031-4BBC-9B28-ACBBA7805F8FQ34776347-67125AA9-0383-4EA8-9756-69251458FD0CQ35056185-F6C4C683-DC33-4B5A-BB7F-5F12A2DD2469Q35091608-54E4852A-6D6D-41E2-AF54-AF16C89AA2B1Q35116623-B4AC365C-6860-4750-B878-D167E338A5A7Q35219906-F568AB32-92CF-4470-B3A1-D53B25444DF5Q35557927-AA1B64D6-8BA1-44D2-A0A4-AC222C2F3ED9Q35559821-F71C62DC-BC36-447F-9EEE-E4C58966FB91Q35604703-F5E3A6EB-3730-462A-B48B-380B1F5E27BDQ35926923-27810626-5BDD-44AA-A9D5-E4A8AE5153E3Q36004290-1BB35A98-3B54-44D0-9856-4525751FF46AQ36111936-ADD2D1DE-0B28-4433-A801-9ADE600BBE5AQ36127237-CFD761C1-13FC-4C04-8E85-FDEEB55BA304Q36164584-F1E050AD-0165-4259-AF7C-B25A59AED52FQ36286283-A380B884-79EC-4254-A662-740840E9F44DQ36516019-F0834E92-7D07-4589-ABD5-A291B2DF625AQ36553321-916523FE-34E3-4237-B81F-896260523E0DQ36591525-80271CCD-6920-4201-948D-D483EA191927Q36676411-508F178A-C07B-4003-9C3A-C650A11064B7Q36686384-22655F39-9157-498F-9F47-AA08E5D96627Q36825800-3B9159AE-37FA-4AC0-A925-03FED1D07A5AQ36847131-BA127B6D-11A2-4355-8B69-438D15B2D0D0
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Glucocorticoids, metabolism and metabolic diseases.
@ast
Glucocorticoids, metabolism and metabolic diseases.
@en
type
label
Glucocorticoids, metabolism and metabolic diseases.
@ast
Glucocorticoids, metabolism and metabolic diseases.
@en
prefLabel
Glucocorticoids, metabolism and metabolic diseases.
@ast
Glucocorticoids, metabolism and metabolic diseases.
@en
P1476
Glucocorticoids, metabolism and metabolic diseases.
@en
P2093
Alexandros Vegiopoulos
P356
10.1016/J.MCE.2007.05.015
P577
2007-06-02T00:00:00Z